Cargando…
MEDB-39. Oncogenic mechanisms underlying GLI2-amplified medulloblastoma
Medulloblastoma (MB) is the most common malignant brain tumor in children. There are several subtypes of MB, and among them, the subtype of GLI2-amplified SHH-MB associated with P53 mutations has the worst prognosis and a poor survival rate; the 5-year survival rate is <30%. Moreover, the GLI2-am...
Autores principales: | Murad, Najiba, Zhang, Jiao, Liu, Xiao, Tao, Ran, Taylor, Michael, Pei, Yanxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165099/ http://dx.doi.org/10.1093/neuonc/noac079.413 |
Ejemplares similares
-
MEDB-36. Clinical and molecular heterogeneity withinMYC andMYCN amplified medulloblastoma
por: Schwalbe, Edward, et al.
Publicado: (2022) -
MEDB-33. The landscape of ecDNA in medulloblastoma
por: Chapman, Owen, et al.
Publicado: (2022) -
MEDB-81. Combined inhibition of CDK11 and EZH2 results in regression of MYC-amplified medulloblastoma
por: Wang, Dong, et al.
Publicado: (2022) -
MEDB-89. Elucidation of the Oncogenic role of Nuclear Factor I/B (NFIB) in group 3 medulloblastoma
por: Perumal, Naveenkumar, et al.
Publicado: (2022) -
MEDB-59. A draft atlas of medulloblastoma cellular evolution under therapy
por: Wang, Lin, et al.
Publicado: (2022)